Table 1.
Target | Drug type | Drugs |
IL 6 signaling | Anti-IL 6 | Clazakizumab, Siltuximab |
Anti-IL6 receptor | Sarilumab, Tocilizumab | |
IL 1 signaling | Anti-IL1β | Canakinumab |
Anti-IL1 repector | Anakinra | |
JAK-STAT signaling | JAK1/JAK2 inhibitors | Baricitinib, Ruxolitinib |
JAK1/JAK3 inhibitors | Tofacitinib |
JAK-STAT: The Janus kinase/signal transducer and activator of tran-ions; IL: Interleukin.